Business Wire

IPsoft and Deloitte Expedite a New Paradigm for the IT Organization Centered on Autonomic and Cognitive Technologies

Del

IPsoft and Deloitte Consulting LLP today announced an alliance that will bring together Deloitte’s leading consulting services and IPsoft’s industry-leading autonomic and cognitive solutions to optimize client operations and enable business growth at scale. By developing go-to-market strategies and consulting around IPsoft’s autonomic and cognitive solutions – IPcenter and Amelia – this alliance between IPsoft and Deloitte will establish industry-focused solutions that resolve known IT pain points for clients in an accelerated implementation timeline.

“Deloitte is focused on bringing an issues-driven approach when tackling business challenges,” said Ranjit Bawa, principal, Deloitte Consulting LLP, and Deloitte cloud and infrastructure leader. “By collaborating with IPsoft, we’re building solutions to solve real client issues and create new opportunities for cost savings and operating efficiencies. The industry is at a great inflection point in autonomics – and together, we’re able to bring our deep-sector knowledge and IPsoft’s innovative solutions to the forefront.”

“Currently, the market lacks expertise in advanced automation. The role of the world’s most trusted consultancies is critical in ensuring enterprises translate the potential of autonomic and cognitive technology into business results,” said Chetan Dube, president and CEO, IPsoft. “Deloitte understands the value of advanced autonomic and cognitive solutions in delivering end-to-end digital services that help clients differentiate themselves in hotly contested global markets. By combining our market leading technology with Deloitte’s intimate knowledge of their clients’ businesses, we can reinvent how an enterprise’s IT operations work closer than ever to the business to deliver tangible benefits. CEOs demand quick returns and those who embrace a digital-labor-first strategy will enjoy an exponential competitive edge.”

The alliance builds on a solid track record of collaboration between the two organizations and capitalizes on the exploding demand for automation solutions. Research shows that self-learning automation solutions will be a “top 5” investment priority for more than 30 percent of CIOs by 20201, fuelling market growth for robotic automation at a CAGR 60.5 percent2. This interest in investment is set against a backdrop of growing pressure to increase the 16% of global IT budgets dedicated to business innovation and reduce the 57% of spending on day to day IT operations*3.

IPcenter, IPsoft’s autonomic IT management platform, for core automation is designed to provide 30% efficiencies within 90 days while reducing mean time to resolution by more than 60%. The company’s innovative cognitive agent, Amelia, is in the early stages of being deployed in a wide range of roles including IT service desk agent for a bank, customer services agent for a local authority, and invoicing query agent for an oil and gas company.

To learn more about IPsoft’s solutions please visit www.ipsoft.com

About IPsoft

IPsoft automates IT and business processes for enterprises across a wide range of industries through the use of digital labor. Through its portfolio of world leading autonomic and cognitive solutions it provides services that allow its clients to secure competitive advantage. Headquartered in New York City, IPsoft has 18 offices in 15 countries across the world and serves more than 500 of the world’s leading brands directly as well as more than half of the world’s largest IT services providers.

About Deloitte Consulting LLP

Deloitte helps organizations grow their businesses and enhance value by identifying actionable insights. More than 35,000 professionals provide a broad range of capabilities across human capital, strategy and operations, innovation, and technology that are aligned to the particular needs of specific sectors, businesses and organizations. Deloitte provides clients with leading business insights that can help generate a tangible and measurable impact.

1 Gartner Predicts 2016: Smart Machines. G00293292
2 Transparency Market Research “The global IT robotic automation market”
3 Deloitte 2015 Global CIO Survey

Contact information

IPsoft
Daniela Zuin, +001 212 708 5521
Marketing Director, IPsoft
daniela.zuin@ipsoft.com
or
Edelman for IPsoft
Erin Pace, 312-297-6900
Erin.Pace@edelman.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 06:00Pressemelding

Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica

The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 05:00Pressemelding

The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort

Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis21.2.2018 21:01Pressemelding

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical

Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 18:00Pressemelding

ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized

Luxoft One of Six Companies Collaborating with Amazon Web Services to Accelerate Blockchain Adoption21.2.2018 16:30Pressemelding

Luxoft Holding Inc (NYSE:LXFT), a global IT service provider, announces today that it is collaborating with Amazon Web Services (AWS) to enable corporates to adopt blockchain and Distributed Ledger Technologies (DLT). Luxoft is one of six IT and consulting services companies to make its blockchain advisory and development services available to AWS users. “We are very excited to be working with AWS to help users engage with blockchain and DLTs,” said Vasiliy Suvorov, Vice President of Technology Strategy at Luxoft. “Blockchain is about removing data silos, improving trust and operational efficiencies. By using AWS to deploy and integrate DLTs into day-to-day processes, businesses can revolutionize how they operate.” Luxoft helps accelerate the deployment and integration of blockchain and DLT-based projects on AWS and is already working on a number of DLT projects using the cloud. For example, Luxoft is building a healthcare claims processing system for a leading healthcare provider usin

Westinghouse Electric Company to Provide Engineering Support at Vandellós 1 in Partnership with EDF21.2.2018 16:30Pressemelding

Westinghouse Electric Company and Electricité de France (EDF), in partnership, announced today that they have been awarded a contract from Empresa Nacional de Residuos Radiactivos (ENRESA), the Spanish agency responsible for radioactive waste management and nuclear plant decommissioning. The agreement covers a four-year engineering support contract for the latency phase of the dismantling and decommissioning project at Vandellós I Nuclear Power Station in Spain and includes the preparation of technical and licensing documentation. “We are extremely pleased that ENRESA has selected Westinghouse and EDF to continue supporting the decommissioning activities at Vandellós I Nuclear Power Station,” said Yves Brachet, Westinghouse vice president, Global Decommissioning, Decontamination, Remediation and Waste Management. “This contract further demonstrates Westinghouse’s global capabilities and expertise in providing innovative decommissioning solutions.” Sylvain Granger, head of EDF's decommi